HB Wealth Management LLC increased its holdings in shares of Cigna Co. (NYSE:CI – Get Rating) by 9.0% in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 4,864 shares of the health services provider's stock after buying an additional 401 shares during the quarter. HB Wealth Management LLC's holdings in Cigna were worth $1,282,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also modified their holdings of the company. Country Trust Bank increased its holdings in Cigna by 116.7% in the 1st quarter. Country Trust Bank now owns 104 shares of the health services provider's stock worth $25,000 after purchasing an additional 56 shares in the last quarter. Pittenger & Anderson Inc. acquired a new position in Cigna in the 2nd quarter worth about $26,000. Wagner Wealth Management LLC increased its holdings in Cigna by 144.4% in the 4th quarter. Wagner Wealth Management LLC now owns 132 shares of the health services provider's stock worth $30,000 after purchasing an additional 78 shares in the last quarter. Exane Derivatives increased its holdings in Cigna by 6,200.0% in the 1st quarter. Exane Derivatives now owns 126 shares of the health services provider's stock worth $30,000 after purchasing an additional 124 shares in the last quarter. Finally, Lloyd Advisory Services LLC. acquired a new position in Cigna in the 1st quarter worth about $30,000. 89.54% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other Cigna news, insider Jason D. Sadler sold 3,458 shares of the stock in a transaction that occurred on Tuesday, June 28th. The stock was sold at an average price of $270.00, for a total value of $933,660.00. Following the transaction, the insider now owns 31,749 shares in the company, valued at $8,572,230. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. In other Cigna news, insider Jason D. Sadler sold 3,458 shares of the stock in a transaction that occurred on Tuesday, June 28th. The stock was sold at an average price of $270.00, for a total value of $933,660.00. Following the transaction, the insider now owns 31,749 shares in the company, valued at $8,572,230. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, EVP Everett Neville sold 5,094 shares of the stock in a transaction that occurred on Thursday, July 7th. The stock was sold at an average price of $275.00, for a total value of $1,400,850.00. Following the completion of the transaction, the executive vice president now owns 7,200 shares in the company, valued at approximately $1,980,000. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 41,158 shares of company stock worth $11,581,956. Corporate insiders own 0.80% of the company's stock.

Cigna Trading Down 1.8 %

Cigna (NYSE:CI – Get Rating) last announced its quarterly earnings results on Thursday, August 4th. The health services provider reported $6.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.62 by $0.60. The business had revenue of $45.48 billion for the quarter, compared to analyst estimates of $44.34 billion. Cigna had a return on equity of 15.91% and a net margin of 3.05%. The company's quarterly revenue was up 5.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $5.24 earnings per share. Research analysts expect that Cigna Co. will post 22.94 earnings per share for the current year.

Cigna Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, September 22nd. Shareholders of record on Wednesday, September 7th were issued a $1.12 dividend. The ex-dividend date of this dividend was Tuesday, September 6th. This represents a $4.48 annualized dividend and a yield of 1.61%. Cigna's payout ratio is currently 26.71%.

Analysts Set New Price Targets

A number of brokerages have issued reports on CI. Deutsche Bank Aktiengesellschaft upped their target price on Cigna from $236.00 to $284.00 in a report on Thursday, June 9th. Jefferies Financial Group reaffirmed a "hold" rating and issued a $271.00 target price (down previously from $330.00) on shares of Cigna in a report on Thursday, July 14th. Loop Capital initiated coverage on Cigna in a report on Thursday, June 16th. They issued a "hold" rating and a $270.00 target price for the company. Credit Suisse Group increased their price target on Cigna from $315.00 to $329.00 and gave the company an "outperform" rating in a research note on Monday, August 8th. Finally, The Goldman Sachs Group increased their price target on Cigna from $273.00 to $311.00 and gave the company a "neutral" rating in a research note on Tuesday, August 9th. Seven analysts have rated the stock with a hold rating, sixteen have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $305.58.

Cigna Company Profile

(Get Rating)

Cigna Corporation provides insurance and related products and services in the United States. Its Evernorth segment provides a range of coordinated and point solution health services, including pharmacy, benefits management, care delivery and management, and intelligence solutions to health plans, employers, government organizations, and health care providers.

Read More

• Get a free copy of the StockNews.com research report on Cigna (CI)
• Will Wall Street's Enthusiasm About Datadog Lead To Big Gains?
• MarketBeat: Week in Review 9/19 – 9/23
• Why Does Tesla Stock Remain Resilient?
• Is Costco's Post-Earnings Price Weakness A Good Time To Buy?
• 2 Semiconductor Stocks To Watch For Reversals

Receive News & Ratings for Cigna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna and related companies with MarketBeat.com's FREE daily email newsletter.